Table 1

Demographic characteristics of the eDelphi panel at rounds 1 and 2. Data are presented as mean (95% CI) for continuous data and frequency count (%) for categorical data.

CharacteristicPanel round 1 (n=674)Panel round 2 (n=439; 65.1%)
Age48.3 (47.3 to 49.3)49.7 (48.5 to 50.8)
Gendermale: 351 (52.1);
female: 316 (46.9);
other: 7 (1.0)
male: 231 (52.6);
female: 206 (46.9);
other 2 (0.5)
Type of response
 Individual565 (83.8)354 (80.6)
 Organisation109 (16.2)85 (19.4)
Category of responder*
 Person with a lived experience of MSK health condition149 (22.1)94 (21.4)
 Registered clinician/health worker517 (76.7)332 (75.6)
 Officer of a clinical/professional organisation149 (22.1)115 (26.2)
 Health policy, service design/implementation officer103 (15.3)74 (16.9)
 Advocacy role126 (18.7)87 (19.8)
 Thought leader†128 (19.0)91 (20.7)
 Academic or workforce training position290 (43.0)199 (45.3)
 WHO officer3 (0.4)3 (0.7)
 National Ministry of Health officer8 (1.2)6 (1.4)
Total years healthcare experience21.1 (20.2 to 22.0)22.2 (21.1 to 23.3)
Total years lived experience with MSK health condition‡18.7 (16.4 to 21.0)20.9 (17.9 to 23.9)
Economic band (World Bank Classifications 2020§)
 High income: by country; by participant39 (54.2); 494 (73.3)37 (56.1); 329 (74.9)
 Low and middle-income: by countries; by participant33 (45.8); 180 (26.7)29 (43.9); 110 (25.1)
Global geographic regions: n (%) participants
 East Asia and Pacific114 (16.9)80 (18.2)
 Europe and Central Asia241 (35.8)172 (39.2)
 Latin America and Caribbean54 (8.0)25 (5.7)
 Middle East and North Africa11 (1.6)5 (1.1)
 North America179 (26.6)106 (24.1)
 Sub-Saharan Africa33 (4.9)22 (5.0)
 South Asia42 (6.2)29 (6.6)
Highest level of education
 Secondary/high school5 (0.7)5 (1.1)
 Diploma/certificate/apprenticeship16 (2.4)6 (1.4)
 University bachelor’s degree83 (12.3)56 (12.8)
 University higher degree (Master’s)200 (29.7)129 (29.4)
 University higher degree (PhD)229 (34.0)164 (37.4)
 University higher degree (other)141 (20.9)79 (18.0)
Clinical disciplines517 (76.7)332 (75.6)
 Complementary medicine practitioner1 (0.2)0 (0)
 Anaesthetist/anaesthesiologist17 (3.3)10 (3.0)
 Chiropractor68 (13.2)52 (15.7)
 Dietitian/nutritionist1 (0.2)1 (0.3)
 Emergency medicine physician1 (0.2)1 (0.3)
 Endocrinologist2 (0.4)2 (0.6)
 Exercise physiologist/scientist2 (0.4)2 (0.6)
 General physician1 (0.2)1 (0.3)
 Gerontologist/geriatrician1 (0.2)1 (0.3)
 Infectious diseases physician2 (0.4)1 (0.3)
 Kinesiologist1 (0.2)0 (0)
 Neurologist3 (0.6)3 (0.9)
 Nurse/nurse practitioner6 (1.2)3 (0.9)
 Occupational therapist23 (4.4)15 (4.5)
 Orthopaedic surgeon41 (7.9)23 (6.9)
 Osteopath3 (0.6)3 (0.9)
 Other manual therapist4 (0.8)2 (0.6)
 Paediatrician5 (1.0)4 (1.2)
 Physician assistant1 (0.2)1 (0.3)
 Physiotherapist/physical therapist222 (42.9)127 (38.3)
 Podiatrist/chiropodist3 (0.6)2 (0.6)
 Primary care/family physician4 (0.8)1 (0.3)
 Psychologist/clinical psychologist2 (0.4)2 (0.6)
 Public health physician2 (0.4)1 (0.3)
 Rehabilitation and physical medicine physician42 (8.1)29 (8.7)
 Rheumatologist (including paediatric rheumatologist)60 (11.6)45 (13.6)
  • *Categories are not mutually exclusive; hence proportions exceed 100%.

  • †Defined as having published at least two peer-reviewed papers or health policies in the last 5 years related to global health systems or health services reform for MSK health, MSK pain, injury, non-communicable disease, ageing, disability or rehabilitation.

  • ‡Answered only by panellists who identified as living with an MSK health condition for at least 5 years.

  • §World Bank Classifications: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.

  • MSK, musculoskeletal; WHO, World Health Organization.